Fast Five Quiz: Relapsed/Refractory Mantle Cell Lymphoma

Ann S. LaCasce, MD, MMSc


January 12, 2023

Mantle cell lymphoma (MCL) is an uncommon type of non-Hodgkin lymphoma that is frequently aggressive. The majority of patients are older and present with advanced-stage disease. While the treatment landscape is rapidly evolving with an increasing number of options, there is still no curative treatment.

Although many patients initially respond to first-line therapy, the duration of remission is generally short. More effective therapies are still needed in patients with relapsed or refractory disease.

How much do you know about relapsed/refractory MCL? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.